Recent broker research reports which have the highest upside or maximum gain potential. Both buy and sell
reports with maximum gain with respect to their targets are available.
Broker Research reports: Maximum gain potential
for Industry - IT Consulting & Software
outlook, evident through weak Q1 deal TCV in BFS. We expect FY26 international growth largely to be flat CC, which translates to an ask-rate of ~0.6% CQGR, while we expect the BSNL add-on will support the growth in Q2/Q3 before it sees further ramp-down in Q4. On the margins, utilization and rationalizing employee pyramid are the major levers, however the low-margin add-on BSNL deal would continue to weigh on FY26 margins. We are adjusting our revenue estimates for the quarterly miss while keeping our margins broadly unchanged. We expect CC revenue to decline by 1.4% in FY26E followed by a...
Tech Mahindra (TECHM) reported 2QFY26 revenue of USD1.6b, up 1.6% QoQ in CC vs. our estimate of 1.0% CC growth. Retail/Manufacturing/BFSI grew 9.0%/5.3%/3.8% QoQ, whereas Communications/Others fell 2.0%/8.8% QoQ (in USD terms).
About the stock: Mastek Ltd (Mastek) offers data, apps, cloud services to public Geographic strength and strategic focus areas: UK remains Mastek's growth anchor, up 4% QoQ and contributing 65% of revenue, driven by strong demand in Healthcare and Government segments. The company is also restructuring its North America leadership to drive Healthcare growth and emphasis remains on profitability improvement and tighter DSO management.in the Middle East. Continued focus on geo-diversification, AI-led delivery, and mid-market leadership provides visibility for steady, profitable growth through FY2627...
Reported revenue stood at $7,421 million, down 0.6% q-o-q/1.1% y-o-y, missing our estimate of $7,587 million. Revenue growth in constant currency (CC) terms stood at -3.3% q-o-q, chiefly led by ramp-down of BSNL deal.
Zensar delivered a strong Q1FY26 performance despite macroeconomic headwinds, reporting revenue of USD 162mn (up 3.3% QoQ), with AI contributing 30% to the active pipeline and 20% to order bookings. Over 50% of its workforce is now trained in AI/GenAI. Growth was led by TMT, BFSI, and healthcare, while manufacturing and consumer services declined slightly. EBITDA stood at 15.2%, down 40 bps due to higher sales and travel costs, while gross profit improved to 30.5%. Order bookings rose 11.7% YoY to USD 172mn, with employee utilization at 84.3%, up 40 bps YoY. The company launched Zen's AI platform, which received...
We hosted the management of HCL Technologies (HCLT) for a two-day NDR in London on 16th-17th Jul’25. Discussions focused heavily on GenAI, delivery model evolution, and margin outlook.
M&A led capability building: M&A has been pivotal to KPIT's capability expansion & profitability. The Caresoft deal (largest in five years) brings CV/off-highway expertise, software benchmarking, and China market access. Earlier, Technica added strengths in E/E architecture & device networking. These targeted acquisitions deepen KPIT's technical moats, scale highgrowth lines rapidly, and support margin accretion via operating leverage as KPIT integrates and cross-utilizes acquired talent & IP across clients. We...
